The biomarker's rapid elevation within 2–4 h of infection offers a temporal advantage over CRP (typically rising after 6–8 h), enabling earlier antibiotic decisions in time-sensitive scenarios like paediatric and neonatal sepsis (37). The gene discussed is CRP; the disease is infection.